Hematological Cancer Clinical Trial
Official title:
Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells : a Randomized Controlled Trial REBOND2-IPC 2022-009
To measure the impact of a coaching program on the patient's health-related quality of life 15 months post-transplant (M15/R12).
After signing the consent form and validating the inclusion and non-inclusion criteria, patients will be included in the study. They will be randomized unequally (2:1) into one of the study groups: - OC (Onco-Coaching) group: patients will undergo onco-coaching sessions at a rate of 1 session/month until 6 months post-inclusion (M9/R6). 73 patients will be randomized in this group - Group C (Control): Patients will not receive onco-coaching follow-up, but will be able to benefit from classical management in full autonomy. 35 patients will be randomized in this group ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03056469 -
Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer
|
N/A | |
| Completed |
NCT01524445 -
Retrospective Survey of Re-treatment With Bortezomib
|
Phase 4 | |
| Recruiting |
NCT03218254 -
MethylphenIdate for Fatigue in Haematological Cancer
|
Phase 3 | |
| Recruiting |
NCT05099237 -
Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester
|
N/A |